To examine whether IMP3 is responsible to maintain reduced levels of the anti-apoptotic Bcl molecules in CRC, we explored Bcl-2 and Bcl-xL expression in HCT-116 cell line treated with or without IMP3 siRNA. This evidence concerns the gene IMP3 and colorectal carcinoma.